MRF Announces Record Date For Rs 229 Per Share Final Dividend: Check Payment Date
India's most expensive stock, MRF Limited, has announced the record date for its final dividend for the financial year 2024–25
MRF Share Price: India's most expensive stock, MRF Limited, has announced the record date for its final dividend for the financial year 2024–25 (FY25). In May, the tyre manufacturing giant declared a final dividend of Rs 229 per share (on a face value of Rs 10), translating to a 2,290% payout, alongside its Q4 results.
MRF Dividend Record Date
In a regulatory filing dated July 3, MRF stated that July 18, 2025, will serve as the record date to determine eligible shareholders for the dividend. Investors must buy MRF shares at least one day before the record date to be eligible, in line with the T+1 settlement cycle followed in Indian markets.
The payment date for the final dividend has been scheduled on or after August 18, 2025, the company added.
MRF AGM Date
MRF also announced the schedule for its 64th Annual General Meeting (AGM). The meeting will be held on Thursday, August 7, 2025, via video conferencing/other audio-visual means, in compliance with guidelines issued by the Ministry of Corporate Affairs and SEBI.
Following the record date announcement, MRF shares traded in the green on the BSE. The stock climbed as high as Rs 1,47,890, marking a 1.9% intraday gain. Despite broader market volatility, MRF shares have gained 13% over the past year. Over a longer horizon, the stock has delivered 121% returns over five years and a remarkable 319% gain over the past decade, firmly placing it among India's multibagger stocks.
First Published:
July 03, 2025, 14:53 IST
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
18 minutes ago
- Business Standard
Carlyle Group may sell 10% stake in Piramal Pharma via block deals: Report
United States-based private equity firm Carlyle Group is planning to divest up to 10 per cent stake in Piramal Pharma through block deals, Moneycontrol reported on Thursday, citing sources. The sale could amount to ₹2,600-2,700 crore, the report added. Piramal Pharma sold 20 per cent of its stake to Carlyle Group in June 2020, in a deal worth ₹3,523 crore. According to stock exchange data, it held 18 per cent stake in the pharma firm as of March 31, 2025. Financial services firm Motilal Oswal has been roped in to facilitate the block deals, the report added. Piramal Pharma operates a diverse and global pharmaceutical business, providing a broad range of products and services. It includes Piramal Pharma Solutions (PPS), a fully integrated contract development and manufacturing organisation (CDMO); Piramal Critical Care (PCC), a complex hospital generics business; and the India Consumer Healthcare business, selling over-the-counter consumer and wellness products. Piramal Pharma Q4 result In the fourth quarter of FY25, Piramal Pharma posted a consolidated revenue from operations of ₹2,754 crore, marking an 8 per cent increase over the ₹2,552 crore recorded in the same quarter last year. The company's EBITDA (earnings before interest, tax, depreciation, and amortisation) also increased by 8 per cent year-on-year to ₹603 crore, up from ₹556 crore. Profit after tax (before exceptional items) came in at ₹154 crore, reflecting a 16 per cent rise compared to ₹132 crore in the corresponding period of the previous financial year. Shares of Piramal Pharma last traded at ₹202.4 apiece on the BSE at the close of the markets on Thursday.
NDTV
20 minutes ago
- NDTV
Explained: How Farm Goods Are Holding Up US-India Trade Deal
US and India trade negotiators were pushing on Wednesday to finalise a tariff-reducing deal ahead of President Donald Trump's July 9 negotiating deadline, but disagreements over US dairy and agriculture remained unresolved. Why are farm goods imports sensitive in India? Agriculture and its allied areas contribute just 16% to India's $3.9 trillion economy, but sustain nearly half of the country's 1.4 billion population. As farmers remain the most powerful voting bloc, Prime Minister Narendra Modi's government was forced into a rare retreat four years ago when it tried to push through controversial farm laws. The prospect of cheaper imports from the United States threatens to drive down local prices, handing the opposition a fresh opportunity to attack the government. New Delhi has traditionally kept agriculture out of Free Trade Agreements with other nations. Granting market access to the US could force India to extend similar concessions to other trading partners. How do Indian and US farms compare? The average Indian farm comprises just 1.08 hectares, compared to 187 hectares in the United States. In dairy, the average herd size in India is two to three animals per farmer, compared to hundreds in the United States. This difference makes it difficult for small Indian farmers to compete with their US counterparts. Farming in India remains largely unmechanised because small, fragmented land holdings leave little room for large machinery. In many regions, farmers rely on techniques passed down through generations, a sharp contrast to US farms, where cutting-edge equipment and AI-driven technologies have raised productivity. Which products is US lobbying for? Why is India resisting? The United States is pressing India to open its markets to a wide range of American products, including dairy, poultry, corn, soybeans, rice, wheat, ethanol, citrus fruits, almonds, pecans, apples, grapes, canned peaches, chocolates, cookies, and frozen French fries. While India is willing to grant greater access to US dry fruits and apples, it is holding back on allowing imports of corn, soybeans, wheat, and dairy products. India does not allow genetically modified (GM) food crops, while most US corn and soybean production is GM-based. Dairy remains a sensitive issue in India, where cultural and dietary preferences strongly influence food choices. Indian consumers are particularly concerned that cattle in the US are often fed with animal by-products, a practice that conflicts with Indian food habits. Why does India oppose US ethanol for bleeding with gasoline? A key aim of India's Ethanol Blended Petrol (EBP) program is to cut dependence on energy imports by blending domestically-produced ethanol with gasoline. Significant investments by domestic companies mean that India is now close to achieving its ambitious target of blending 20% ethanol. Importing ethanol would undermine those companies. The EBP also helps manage surpluses of rice, sugarcane, and corn by diverting them to ethanol production. Allowing imports of US ethanol would be a serious setback for India's emerging distillery sector.
&w=3840&q=100)
Business Standard
26 minutes ago
- Business Standard
Amitabh Kant appointed to IndiGo's board as non-executive director
InterGlobe Aviation, the parent company of IndiGo airline, has appointed former bureaucrat Amitabh Kant as a Non-Executive Director on its Board, the airline said in a statement on Thursday. Kant, a retired Indian Administrative Service (IAS) officer of the 1980 Kerala cadre, has held several senior positions in the Indian government. Most recently, he served as India's G20 Sherpa during the country's presidency. He played a key role in drafting the New Delhi Leaders' Declaration in September 2023. Over a four-decade-long career, Kant also served as CEO of NITI Aayog for six years, where he led programs such as the Aspirational Districts Programme and initiatives on mobility and sustainability. He has previously held board positions at the National Highways Authority of India and was a member of the National Statistical Commission. IndiGo said it expects to leverage Kant's experience in public policy, infrastructure development, and international engagement as it expands its global network. The airline is targeting international growth as part of its 2030 strategy. IndiGo is India's largest airline with more than 60 per cent share in the domestic passenger market. Kant said, 'In under two decades, IndiGo has transformed air travel in India. With its scale, efficiency, and international ambition, IndiGo will open up new markets for India and transform airports into global hubs of connectivity and commerce.' Vikram Singh Mehta, Chairman of the Board of Directors at IndiGo, said, 'Mr. Kant's administrative experience and leadership in delivering projects of global scale will benefit IndiGo, especially in its international expansion efforts.'
